When is genetic carrier screening recommended for BRCA gene mutation?

BRCA1 and BRCA2 changes can be inherited. Screening may help clarify whether a reproductive partner carries a relevant change as well. The result can guide a conversation about the chance of passing an inherited change to a child and which family-building choices may be available.

This screening is different from testing whether someone has a BRCA mutation themselves. A person who has a known familial change should discuss targeted testing and genetic advice, because the right test depends on the exact variant and family history.

Before testing, share the known BRCA result, the laboratory report if available, and relevant family history with a qualified clinician. Ask whether testing the reproductive partner is appropriate, what the laboratory will test, how results are reported, and how the information could affect relatives or future children. Testing is a personal choice and can be arranged before or during family-planning discussions.

Arrange genetic advice promptly when a BRCA change has been identified and pregnancy or biological parenthood is being considered. Early discussion allows time to understand testing, possible results, and reproductive options before decisions become time-sensitive. A result does not replace cancer screening or treatment advice.

Ask: Do I have the exact BRCA variant report? Should my partner be tested? What does a positive, negative, or uncertain result mean? Who can access the result? Could testing change care for relatives? What family-building options should we discuss?